Choroid plexus tumors (CPTs) are rare intraventricular neoplasms arising from the epithelial cells of the choroid plexus, a structure essential for cerebrospinal fluid (CSF) production and regulation. ^{1, 2} Their incidence varies with age, accounting for approximately 1–4% of pediatric brain tumors and 0.4–1% of intracranial tumors in adults. ³

Because of their intraventricular location and frequent CSF overproduction, CPTs commonly cause hydrocephalus and intracranial hypertension, with clinical manifestations depending on tumor size and ventricular site. ^{3, 4} Diagnosis is primarily based on magnetic resonance imaging (MRI) and confirmed by histopathological examination. ⁵ According to the 2021 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (5th edition), CPTs are classified as choroid plexus papilloma (CPP, WHO grade I), atypical choroid plexus papilloma (aCPP, WHO grade II), and choroid plexus carcinoma (CPC, WHO grade III), the latter representing an aggressive malignant entity. ^{6, 7}

Surgical resection remains the cornerstone of treatment, although management is often challenging because of marked tumor vascularity and complex anatomy, particularly in infants and young children. ^{8, 9}

Given the rarity of CPTs and the heterogeneity of their presentation and outcomes, we report our institutional experience, focusing on clinical, radiological, histopathological, therapeutic, and outcome-related characteristics.

We conducted a retrospective descriptive study including all patients treated for choroid plexus tumors at the Neurosurgery Department of Habib Bourguiba University Hospital (Sfax) between January 2010 and December 2023, regardless of age or sex.

Clinical data included age, sex, presenting symptoms, neurological examination findings, and diagnostic delay. Radiological evaluation was based on CT and MRI, assessing tumor location, laterality, ventricular site, parenchymal extension, hydrocephalus, calcifications, mass effect, and contrast enhancement.

Surgical variables included time to surgery, preoperative cerebrospinal fluid diversion, surgical approach, intraoperative tumor characteristics, extent of resection, operative duration, and perioperative complications. Histopathological analysis focused on tumor subtype, cellularity, nuclear pleomorphism, mitotic activity, necrosis, solid growth patterns, and immunohistochemical findings.

Postoperative outcomes, adjuvant treatments, complications, recurrence, and survival were recorded during follow-up at 3 months, 1 year, and 5 years.

Analysis was based on the calculation of medians with ranges for quantitative variables and frequencies for qualitative variables.

Between January 2010 and December 2023, seven patients with choroid plexus tumors were treated at our institution. Histologically, four tumors were choroid plexus papillomas (CPP) and three were choroid plexus carcinomas (CPC). Median age at diagnosis was 2 years (range: 2 months and 20 days–28 years), with six pediatric patients and one young adult. There was a female predominance (5 females, 2 males).

Choroid plexus tumors (CPTs) are rare intraventricular neoplasms, predominantly affecting the pediatric population, particularly during the first years of life. ^{1, 3} In our series, the median age at diagnosis was 2 years, with six of seven patients being children, reflecting the well-documented pediatric predominance of these tumors. The sex ratio was 2:5, indicating a slight female predominance, contrasting with some reports of equal distribution or slight male predominance. ⁸ Tumor characteristics varied by sex, location, and histology: cerebellopontine angle tumors were associated with older age, benign histology, and female sex, ^{4, 10} consistent with our oldest patient (28 y, CPP, 4th ventricle extending to CPA). In contrast, infantile CPTs were mostly lateral ventricular and more common in males. ¹

Clinical presentation was dominated by symptoms of increased intracranial pressure, mainly vomiting and headache, reflecting the high prevalence of hydrocephalus in CPTs. The median diagnostic delay was short (7 days), likely related to the rapid onset of symptoms in pediatric patients, particularly infants, in whom hydrocephalus manifests early with macrocephaly, lethargy, or irritability. This contrasts with adult patients, in whom intraventricular tumors may remain asymptomatic for longer periods. ^{9, 11, 12}

Radiologically, our findings were concordant with the literature. CPPs typically appeared as well-circumscribed intraventricular masses with homogeneous enhancement, whereas CPCs demonstrated heterogeneous enhancement, calcifications, and parenchymal invasion causing vasogenic edema. ^{12, 13} Diffusion-weighted imaging shows hypercellularity with restricted diffusion, and spectroscopy may help distinguish CPPs (myo-inositol peak) from CPCs (choline elevation). ^{11, 14} Despite these suggestive features, differentiation between CPP and CPC based solely on imaging remained difficult, reinforcing the central role of histopathological examination for definitive diagnosis.

Surgical management remains the cornerstone of treatment. ^{8, 15} Gross total resection was achieved in the majority of CPP cases and was associated with excellent long-term outcomes, with no recurrences observed during follow-up. Management of CPCs remains challenging: complete excision is the goal but often difficult due to hypervascularity and invasive behavior. Infants and young children are particularly vulnerable to blood loss; excessive intraoperative bleeding can result in perioperative mortality, ¹⁶ as observed in one of our patients. Collaboration with anesthesiology teams experienced in pediatric neuro-oncology is essential. Preoperative embolization has been proposed to reduce bleeding but is technically challenging due to small, tortuous feeding vessels ¹⁷ ; MR angiography can assist in delineating the surgical corridor.

CSF diversion is also a critical component of management. ¹⁸ Hydrocephalus, common in CPTs, may rapidly impair consciousness and sometimes requires urgent external ventricular drainage (EVD). Hydrocephalus often resolves after tumor resection, allowing EVD removal, but persistent obstruction due to necrotic debris, hemorrhage, or arachnoiditis may necessitate ventriculoperitoneal shunting. ^{4, 8} Thus careful monitoring of ventricular size and intracranial pressure is mandatory. Postoperative subdural hygroma, a recognized complication after transcortical approaches in children, was also observed and successfully managed with cerebrospinal fluid diversion. ¹⁸

Histopathological examination remains the gold standard for the definitive diagnosis and grading of choroid plexus tumors. In our series, histological features were fully consistent with the 2021 WHO Classification of Tumors of the Central Nervous System (5th edition). CPPs displayed classic papillary architecture with low cellularity, absent atypia, and negligible mitotic activity, consistent with indolent, low-grade behavior, whereas CPCs exhibited high cellularity, nuclear pleomorphism, necrosis, and elevated Ki-67 (up to 40%), reflecting aggressive malignancy in line with WHO criteria. The diagnosis of CPC requires the presence of at least four of five histological features—high cellularity, nuclear pleomorphism, loss of papillary architecture, necrosis, and increased mitotic activity—which were met in our CPC cases. ^{6, 7, 19} Immunohistochemistry confirmed the epithelial origin of CPCs, which showed high Ki-67 proliferation indices (up to 40%) reflecting aggressive behavior, whereas CPPs exhibited very low Ki-67 (<1%), consistent with indolent biology. ^{12, 19}

At the molecular level, alterations of the TP53 pathway play a central role in choroid plexus tumorigenesis, particularly in choroid plexus carcinomas, where TP53 mutations are reported in up to 50% of cases. ^{20, 21} Germline TP53 mutations, as seen in Li–Fraumeni syndrome, are strongly associated with pediatric CPC and carry important prognostic and therapeutic implications. ^{5, 12, 22}

For CPCs, chemotherapy after incomplete resection can reduce tumor size and vascularity. From a therapeutic perspective, adjuvant chemotherapy and radiotherapy have been shown to improve survival in CPC patients, particularly following incomplete resection. ^{16, 23} However, the use of radiotherapy in infants is limited by its long-term neurocognitive and endocrine toxicity. ²⁴ In our series, adjuvant treatment could not be administered due to early postoperative mortality or rapid clinical deterioration, which likely contributed to the poor outcomes observed in CPC patients.

Successful management of pediatric CPTs requires a multidisciplinary approach, meticulous preoperative planning, microsurgical expertise, proactive CSF management, and close postoperative surveillance. Tailoring the surgical strategy to tumor type, patient age, and vascular characteristics significantly reduces perioperative morbidity and improves long-term outcomes.

Overall, our findings reinforce the heterogeneity of CPTs. Complete surgical resection remains the key determinant of outcome in CPTs, while CPCs continue to carry a poor prognosis, highlighting the need for improved perioperative strategies and molecular-guided therapies.

This retrospective descriptive study was conducted in accordance with the principles of the Declaration of Helsinki. Authorization to access patient medical records was obtained from the administration of Habib Bourguiba University Hospital. The study involved the analysis of anonymized data collected as part of routine clinical care, with no additional diagnostic or therapeutic procedures. No patient-identifying information was included. Given the retrospective, non-interventional nature of the study, formal approval from a local Institutional Review Board or Ethics Committee was not required, and the requirement for informed consent was waived in accordance with institutional policies.